Investor’s Ready to act on these stocks: eBay Inc. (EBAY), Akers Biosciences Inc. (AKER)

27

eBay Inc. (EBAY)

eBay Inc. is a global commerce leader, which includes our Marketplace, StubHub and Classifieds platforms. Collectively, eBay connect millions of buyers and sellers around the world. The technologies and services that power platforms are designed to enable sellers worldwide to organize and offer their inventory for sale, and buyers to find and purchase it, virtually anytime and anywhere. eBay Marketplace platforms include online marketplace located at www.ebay.com, its localized counterparts and the eBay mobile apps. eBay believe that these are among the world’s largest and most vibrant marketplaces for discovering great value and unique selection. eBay StubHub platforms include online ticket platform located at www.stubhub.com, its localized counterparts, the StubHub mobile apps and Ticketbis. These platforms connect fans with their favorite sporting events, shows and artists and enable them to buy and sell tens of thousands of tickets whenever they want.

eBay Inc. (EBAY)‘s Financial Overview

eBay Inc. (EBAY) declined -0.27% yesterday to close its trading session at $40.11. The company has 1 year Price Target of $47.48. eBay Inc. has 52-Week high of $46.99 and 52-Week Low of $31.89. The stock touched its 52-Week High on Obsolete and 52-Week Low on Obsolete. The stock traded with the volume of 14.32 Million shares yesterday. The firm shows the market capitalization of $41.48 Billion.

eBay Inc. (EBAY) reported its last quarterly earnings on 12/30/2017 where the firm reported its Actual EPS of $0.59/share against the analyst consensus estimate of $0.59/share.

The firm is trading with SMA20 of -5.36 Percent, SMA50 of SMA50 Percent and SMA200 of 5.62 percent. eBay Inc. has P/S value of 4.34 while its P/B value stands at 5.14. Similarly, the company has Return on Assets of -3.9 percent, Return on Equity of -9.6 percent and Return on Investment of 11.5 Percent. The company shows Gross Margin and Operating Margin of 76.8 percent and 23.7 percent respectively.

The Stock currently has Analyst’ mean Recommendation of 2.4 where the scale is from 1 to 5, 1 means Strong Buy and 5 means Sell.

The 30 analysts offering 12-month price forecasts for eBay Inc have a median target of 48.50, with a high estimate of 55.00 and a low estimate of 36.00. The median estimate represents a +20.92% increase from the last price of 40.11.

Akers Biosciences Inc. (AKER)

Akers Biosciences, Inc. develops, manufactures and supplies rapid, point-of-care screening and testing products. The Company’s products primarily includes BreathScan(R), BreathScan PRO(R), METRON(R), VIVO(TM), Heparin/PF4 Antibody Serum Panels(R) and Breath Ketone. Akers Biosciences, Inc. is based in Thorofare, United States.

Akers Biosciences Inc. (AKER)’s Financial Outlook

The 1 analysts offering 12-month price forecasts for Akers Biosciences Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +381.98% increase from the last price of 0.83.

According to Zacks Investment Research, Akers Biosciences Inc. has a Consensus Recommendation of NA. (The Scale is from 1-5 where 1 means Strong Buy and 5 means Strong Sell).

The Stock declined-5.58% and closed its last trading session at $0.83. The company has the market capitalization of $62.47 Million. The stock has 52-week high of $2.295 and 52-Week low of $0.122. The firm touched its 52-Week high on Obsolete and 52-Week low on Obsolete. The company has volume of 14.32 Million shares. The company has a total of 75.28 Million shares outstanding.

The company has YTD performance of 519.33 percent. Beta for Akers Biosciences Inc. stands at -1.01 while its ATR (average true range) is 0.09. The company has Weekly Volatility of 11.75%% and Monthly Volatility of 12.19%.

Akers Biosciences Inc. has distance from 20-day Simple Moving Average (SMA20) of 12.01%, Distance from 50-Day Simple Moving Average of SMA50 percent and Distance from 200-Day Simple Moving Average of 10.84%.

The Company currently has ROA (Return on Assets) of -74.8 percent, Return on Equity (ROE) of -99.9 Percent and Return on Investment (ROI) of -97.9% with Gross margin of 61.9 percent.

 

SHARE